Pharmacokinetic, Dosimetry and Toxicity Study of ¹⁷⁷Lu-EDTMP in Patients: Phase 0/I study

E-ISSN： 1874-4729|9|1|71-84

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.9, Iss.1, 2015-11, pp. : 71-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of ¹⁷⁷Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 64-70

Bentham Science Publishers

Access to resources Recommend Favorite

Radiation Dosimetry Aspects of ¹⁷⁷Lu

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 139-144

Bentham Science Publishers

Access to resources Recommend Favorite

Consequences of meta-stable ^177mLu admixture in ¹⁷⁷Lu for patient dosimetry

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 145-149

Bentham Science Publishers

Access to resources Recommend Favorite

Alternative method to determine Specific Activity of ¹⁷⁷Lu by HPLC

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 119-122

Bentham Science Publishers

Access to resources Recommend Favorite

Chemistry and bifunctional chelating agents for binding ¹⁷⁷Lu

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 86-94

Bentham Science Publishers

Access to resources Recommend Favorite